Submit Deal

Submit Deal

Cover Image Peter Svennilson

Peter Svennilson

‎Founder and Managing Partner at THE COLUMN GROUP

Investor

Deal Bio

Total Deals6

Valued Deals6

Total Value£ 823 M

Avg. Deal Size£ 137 M

Market Context

Sort

06 Jan 2022|United States|Biotechnology

Target: EIKON THERAPEUTICS INC

Bidder: HAREL GROUP

19 Service Providers

2 Target | 17 Bidder

21 Dealmakers

3 Target | 18 Bidder

£ 382 M

Value

28 Nov 2022|United States|Biotechnology

Target: ESCIENT PHARMACEUTICALS

Bidder: ABINGWORTH MANAGEMENT

13 Service Providers

1 Target | 12 Bidder

14 Dealmakers

2 Target | 12 Bidder

£ 99 M

Value

06 Jan 2023|United States|Biotechnology

Target: SYNTHEKINE

Bidder: THE COLUMN GROUP

3 Service Providers

2 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 83 M

Value

25 May 2023|United States|Biotechnology

Target: CARMOT THERAPEUTICS

Bidder: DEEP TRACK CAPITAL

12 Service Providers

2 Target | 10 Bidder

18 Dealmakers

1 Target | 17 Bidder

£ 120 M

Value

26 Feb 2024|United States|Pharmaceuticals

Target: NGM BIO

Bidder: THE COLUMN GROUP

5 Service Providers

3 Target | 2 Bidder

11 Dealmakers

1 Target | 10 Bidder

£ 78 M

Value

23 Jan 2024|United States|Pharmaceuticals

Target: ACCENT THERAPEUTICS

Bidder: MIRAE ASSET CAPITAL CO LTD

15 Service Providers

2 Target | 13 Bidder

15 Dealmakers

2 Target | 13 Bidder

£ 58 M

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite